课题基金 / 基金详情

The study of tumor growth inhibiting activity purified from conditioned medium of human malignant melanoma cells

The study of tumor growth inhibiting activity purified from conditioned medium of human malignant melanoma cells
人恶性黑色素瘤细胞条件培养基纯化的肿瘤生长抑制活性研究
批准号:
12470436
负责人:
INUI Madoka
金额:
$7.36万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

INUI Madoka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the present study, we purified the growth-inhibitory factors released by cultured MMN9 melanoma cells and identified one factor to be β_2-microglobulin (β_2M). Exogenous b2M induced apoposis in all melanoma cell lines tested but not normal fibroblasts. Thus, β_2M is a pro-apoptotic factor. The general caspase inhibitor Z-VAD-fmk and the caspase-3/-7 inhibitor DEVD-CHO did not block β_2M-induced apoptosis, indicating β_2M-induced apoposis does not involve the caspase-dependent pathway that characterizes the classical Fas-mediated apoptosis. Furthermore, bcl-2 expression did not alter during β_2M-induced apoptosis and the cleaved bcl-2 band that appears during Fas-mediated apoptosis of MMN9 cells was never observed. However, expression of the pro-apoptotic bax and bak molecules was upregulated later in β_2M-induced apoptosis. Thus, β_2M-induced apoptosis may involve bak- and bax-dependent apoptotic pathways. The morphological features of β_2M-induced apoptosis are similar to those observed in apoposis induced by the antibody ligation of MHC I molecules. In addition, like MHC I ligation-induced apoptosis, PI-3 kinase was activated at an early stage of β_2M-induced apoptosis and the PI-3 kinase inhibitor wortmannin blocked this apoptosis. Thus, β_2M-induced apoptosis of MMN9 melanoma cells may involve a signal sent through the MHC I molecule that activates PI-3 kinase, which in turn activates the bcl-2 oncoprotein family at a later stage of apoptosis. Understanding the apoptotic pathway induced by β_2M may suggest useful therapeutic strategies that aim to eliminate melanoma cells.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Takahiko Kamei, et al.: "Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines, and its relationship to bcl-2 cleavage bak expression"Melanoma Research. (In press). (2003)
Takahiko Kamei 等人:“干扰素-γ 和抗 Fas 抗体诱导的人黑色素瘤细胞系凋亡及其与 bcl-2 裂解 bak 表达的关系”黑色素瘤研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中村真之介他: "ヒト悪性黒色腫細胞より得られた腫瘍増殖抑制活性因子の精製(第3報)"口腔組織培養研究誌. 10. 19-20 (2001)
Shinnosuke Nakamura等人:“从人恶性黑色素瘤细胞中获得的肿瘤生长抑制活性因子的纯化(第3次报告)”口腔组织培养研究杂志10. 19-20(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahiko Kamei, et al.: "Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines, and its relationship to bcl-2 cleavage and bak expression"Melanoma Research. 13. 153-159 (2003)
Takahiko Kamei 等人:“干扰素-γ 和抗 Fas 抗体诱导的人黑色素瘤细胞系凋亡,及其与 bcl-2 裂解和 bak 表达的关系”黑色素瘤研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S Nakamura, M Inui, T Kamei, T Murata, T Tagawa: "Reducing bak expression by introduction of bcl-2 antisense oligodeoxynucleotide (AS-ODN) to malignant melanoma cell, and the interaction of bcl-2 and bak mediated by p53"Pigment Cell Research. Vol 15. 69 (
S Nakamura、M Inui、T Kamei、T Murata、T Takawa:“通过将 bcl-2 反义寡脱氧核苷酸 (AS-ODN) 引入恶性黑色素瘤细胞来减少 bak 表达,以及 p53 介导的 bcl-2 和 bak 的相互作用”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Experimental chemotherapy of anti-human melanoma antibody conjugated antitumor agent.
    • 批准号:
      04454498
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.35万
    • 财政年份:
      1992
    • 负责人:
      INUI Madoka
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: